|
Volumn 352, Issue 6, 2005, Pages 628-630
|
Dexamethasone for tuberculous meningitis [4] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYTOCHROME P450;
DEXAMETHASONE;
HYDROCORTISONE;
RIFAMPICIN;
GLUCOCORTICOID;
IMMUNOLOGICAL ADJUVANT;
TUBERCULOSTATIC AGENT;
ADDISON DISEASE;
ADULT;
BRAIN DISEASE;
CLINICAL TRIAL;
COMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DISABILITY;
DRUG POTENCY;
GLASGOW COMA SCALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYDROCORTISONE BLOOD LEVEL;
LETTER;
MENINGITIS;
MORBIDITY;
MORTALITY;
NEUROLOGIC DISEASE;
PERIARTHRITIS;
PRIORITY JOURNAL;
RISK;
TUBERCULOUS MENINGITIS;
ADOLESCENT;
COHORT ANALYSIS;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
DRUG INTERACTION;
ADJUVANTS, IMMUNOLOGIC;
ADOLESCENT;
ADULT;
COHORT STUDIES;
DEXAMETHASONE;
GLUCOCORTICOIDS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
TUBERCULOSIS, MENINGEAL;
ANTIBIOTICS, ANTITUBERCULAR;
DRUG INTERACTIONS;
RIFAMPIN;
|
EID: 13744262725
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200502103520620 Document Type: Letter |
Times cited : (6)
|
References (0)
|